AMED... own 983 shares worth $25,577.00
http://online.wsj.com/article/SB10001424052748703625304575116040870004462.html
for the bad
http://www.amedisys.com
for amedisys response
90% of revenue from medicare.
Headwinds from Regulators and "declining recertifications of patients" which has caused decrease of revenues when ramping up of expenses is occurring.
Saturday, July 17, 2010
Thursday, March 11, 2010
Monday, March 1, 2010
Warren Buffet Advise
Probably to best way to protect you capital is to invest it in companies that have good management and track records. They must be purchased at the right price.
Sunday, February 14, 2010
Saturday, February 6, 2010
Dendreon
Recommended by Valerie Kramer this week on CNBC.
Listened to the presentation outlining progress that this company has made to get its product "Provenge" to the market. Reviewed the yahoo message board on this stock.
Noted that it has a $4 Billion market capitalization. Considered selling Biogen-Ideac and buying DNDN.
Immunotherapy looks promising for tumors resistant to more traditional therapy
Listened to the presentation outlining progress that this company has made to get its product "Provenge" to the market. Reviewed the yahoo message board on this stock.
Noted that it has a $4 Billion market capitalization. Considered selling Biogen-Ideac and buying DNDN.
Immunotherapy looks promising for tumors resistant to more traditional therapy
Subscribe to:
Posts (Atom)